Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H20N2O3 |
Molecular Weight | 288.3416 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(N[C@H]1CN2CCC1CC2)C3=CC4=C(OCCO4)C=C3
InChI
InChIKey=LUVXHMJTVXZFPD-ZDUSSCGKSA-N
InChI=1S/C16H20N2O3/c19-16(17-13-10-18-5-3-11(13)4-6-18)12-1-2-14-15(9-12)21-8-7-20-14/h1-2,9,11,13H,3-8,10H2,(H,17,19)/t13-/m0/s1
Molecular Formula | C16H20N2O3 |
Molecular Weight | 288.3416 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2111332 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17011782 |
2.8 µM [Ki] | ||
Target ID: CHEMBL2492 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17011782 |
44.0 nM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Enantiomeric purity methods for three pharmaceutical compounds by electrokinetic capillary chromatography utilizing highly sulfated-gamma-cyclodextrin as the chiral selector. | 2006 Sep 15 |
|
Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress. | 2014 |
|
Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in mice. | 2015 Mar 17 |
|
Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonists. | 2015 Oct 15 |
|
Activation of Alpha-7 Nicotinic Acetylcholine Receptor Reduces Brain Edema in Mice with Ischemic Stroke and Bone Fracture. | 2017 Dec |
|
α7 nicotinic acetylcholine receptor agonist inhibits the damage of rat hippocampal neurons by TLR4/Myd88/NF‑κB signaling pathway during cardiopulmonary bypass. | 2017 Oct |
|
In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia. | 2018 Aug |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:37:08 GMT 2023
by
admin
on
Fri Dec 15 16:37:08 GMT 2023
|
Record UNII |
C9IF5SIJ2I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID1047285
Created by
admin on Fri Dec 15 16:37:08 GMT 2023 , Edited by admin on Fri Dec 15 16:37:08 GMT 2023
|
PRIMARY | |||
|
C9IF5SIJ2I
Created by
admin on Fri Dec 15 16:37:08 GMT 2023 , Edited by admin on Fri Dec 15 16:37:08 GMT 2023
|
PRIMARY | |||
|
9932000
Created by
admin on Fri Dec 15 16:37:08 GMT 2023 , Edited by admin on Fri Dec 15 16:37:08 GMT 2023
|
PRIMARY | |||
|
527680-56-4
Created by
admin on Fri Dec 15 16:37:08 GMT 2023 , Edited by admin on Fri Dec 15 16:37:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
(.ALPHA.7 NACHR) IN VITRO DATA KI = 8.8 +/- 1.3 NM
|